Maynard Um
-
-
-
-
-
-
-
Dyne Therapeutics Inc. (DYN) call put ratio 1.1 calls to 1 put as share price down 1.5%
-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Dyne Therapeutics (DYN)
-
-
-
-
-
-
-
Jefferies on Dyne Therapeutics (DYN): 'We remain 70-80%+ confident in an AA approval by Q1:27'
-
-
-
-
-
-
-
Dyne Therapeutics receives orphan drug designation in Japan for DM1 treatment
-
-
-
-
-
-
-
Dyne Therapeutics (DYN) PT Raised to $40 at Raymond James
-
-
-
-
-
-
-
Dyne Therapeutics gets orphan drug status in Japan for DMD therapy
-
-
-
-
-
-
-
Dynegy (DYN) Misses Q2 EPS by 3c
-
444,171 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

